Press Releases

News and views on research at the Helmholtz Association - this is the place to look for all the press releases issued by the Helmholtz Research Centres and the Helmholtz Head Office. A comfortable search function helps you to view specific news items from the Helmholtz Research Centres in chronological order. Older press releases can be found in our archive or on the website of the relevant Helmholtz Research Centre.

At present only a selection of press releases is available in English - switch to the German version with the topmost navigation bar for a complete overview.

Your Results 1 - 10 / 3257
  • 15. April 2021, Forschungszentrum Jülich
    Transparent nanolayers for more solar power

    Jülich, 16 April 2021 – There is no cheaper way to generate electricity today than with the sun. Power plants are currently being built in sunny locations that will supply solar electricity for less than two cents per kilowatt hour. Solar cells available on the market based on crystalline silicon make this possible with efficiencies of up to 23 percent. Therefore they hold a global market share of around 95 percent. With even higher efficiencies of more than 26 percent, costs could fall further. An international working group led by photovoltaics researchers from Forschungszentrum Jülich now plan to reach this goal with a nanostructured, transparent material for the front of solar cells and a sophisticated design. The scientists report on their success of many years of research in the renowned scientific journal "Nature Energy".

    To press release
  • 14. April 2021, Forschungszentrum Jülich
    Impacts of Coronavirus Lockdowns: New Study Collects Data on Pollutants in the Atmosphere

    Jülich, 13 April 2021 – One consequence of the coronavirus pandemic has been global restrictions on mobility. This, in turn, has had an effect on pollution levels in the atmosphere. Researchers from across the world are using this unique opportunity to take measurements, collect data, and publish studies. An international team led by Forschungszentrum Jülich's Institute of Climate and Energy Research – Troposphere has now published a comprehensive review providing an overview of results up to September 2020. The study also has its own dedicated website, where additional measurement data can be added to supplement and refine existing research results At the same time, this collection of data allows scientifically substantiated predictions to be made about the pollution levels of future mobility scenarios.

    To press release
  • 14. April 2021, German Cancer Research Center (DKFZ)
    Engineering T cells for cancer therapy efficiently and safely

    Genetically enhancing a patient's immune cells by adding therapeutic genes to them outside the body is regarded as a promising new treatment approach in oncology. However, the production of these therapeutic cells using viruses is not only expensive but time-consuming. Researchers at the German Cancer Research Center (DKFZ) have developed an innovative non-viral vector that can efficiently introduce therapeutic genes into immune cells. At the National Center of Tumor Diseases (NCT) Heidelberg, therapeutic T cells produced with the novel vector were able to target and fight cancer more efficiently than conventionally produced cellular therapies.

    To press release
  • 13. April 2021, Karlsruhe Institute of Technology (KIT)
    Anti-reflective Films: What High-tech Can Learn from Plants

    KIT Spinoff Phytonics Develops an Antireflective Film Modeled on Petals - Innovation to be Experienced Digitally at Hannover Messe 2021 from April 12 to 16

    To press release
  • 13. April 2021, German Cancer Research Center (DKFZ)
    beLAB 2122: A new bridge connects research and industry

    Drug discovery alliance and development partnership company Evotec launches „beLAB2122", translating academic innovation from leading German Life Science Region in collaboration with Bristol Myers Squibb. The German Cancer Research Center (DKFZ) is one of the academic partners of the cooperation project.

    To press release
  • 12. April 2021, Karlsruhe Institute of Technology (KIT)
    A Molecule That Responds to Light

    A novel Light-Spin Interface with Europium(III) Molecule Advances Development of Quantum Computers - KIT Researchers Report in Nature Communications

    To press release
  • 08. April 2021, Helmholtz Centre for Infection Research (HZI)
    iCAIR® consortium delivers first results on the way to inhalable drugs against SARS-CoV-2

    Active substances from approved pancreatic drugs prevent virus entry into the cell. While the first vaccines against SARS-CoV-2 have now been approved in Europe and other countries, drugs for specific and efficient treatment of COVID-19 have as yet only limited availability – but are urgently needed. Because of the typical long drug development timelines, the approach of iCAIR® researchers is based on drug repurposing – the use of drugs that have already been approved ...

    To press release
  • 06. April 2021, Helmholtz Centre for Infection Research (HZI)
    New viruses, new challenges

    HZI researchers Luka Cicin-Sain and Carlos Guzmán on future approaches to stop new pathogens more quickly. Viruses are small particles - about 1000x smaller than human cells - that exploit their host's metabolism to replicate. There are many thousands of viruses circulating in the animal world that could spread to humans. SARS-CoV-2 has shown how quickly new viruses can spread worldwide. However, viruses also have to meet some requirements to be able to replicate in a new host. In the cover ...

    To press release
  • 02. April 2021, Deutsches Elektronen-Synchrotron DESY
    DESY X-ray lightsource identifies promising candidates for COVID drugs

    A team of researchers has identified several candidates for drugs against the coronavirus SARS-CoV-2 at DESY´s high-brilliance X-ray lightsource PETRA III. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. In a so-called X-ray screening, the researchers, under the leadership of DESY, tested almost 6000 known active substances that already exist for the treatment of other diseases in a short amount of time. After measuring about 7000 samples, the team was able to identify a total of 37 substances that bind to the main protease (Mpro) of the SARS-CoV-2 virus, as the scientists report online today in the journal Science. Seven of these substances inhibit the activity of the protein and thus slow down the multiplication of the virus. Two of them do this so promisingly that they are currently under further investigation in preclinical studies. This drug screening – probably the largest of its kind – also revealed a new binding site on the main protease of the virus to which drugs can couple.

    To press release
  • 31. March 2021, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
    GNC health study examines former soccer players

    In the last week of March, the German National Cohort’s Berlin-North Study Center received some special guests: Former professional soccer players Claudia Müller and Sven Kretschmer underwent preliminary examinations as part of a soccer study being conducted by the GNC’s sponsoring association.

    To press release
Your Results 1 - 10 / 3257
Print Version


Subscribe to feed

Press Releases